Dr. Naveen Kumar Devabhaktuni, MD

Dr. Devabhaktuni practices at Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana.

Dr. Devabhaktuni's NPI, 1679586705, was assigned on August 13, 2006. Dr. Devabhaktuni holds Indiana license 01062372A.

Dr. Devabhaktuni's primary practice is Deaconess Midtown Hospital - Outpatient Therapy, at 600 Mary St, Evansville, IN 47747. The practice phone is (812) 450-3324.

Dr. Devabhaktuni's primary practice is Deaconess Midtown Hospital - Outpatient Therapy in Evansville, Indiana. Dr. Devabhaktuni is also affiliated with Deaconess Midtown Hospital. The medical group on file is Deaconess Health System. Dmand AI also links Dr. Devabhaktuni to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devabhaktuni practices, 9 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Devabhaktuni's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Devabhaktuni is licensed in Indiana.

CMS data shows 4,130 Medicare services from Dr. Devabhaktuni across 27 procedure codes in 2024, for 1,993 Medicare patients. Medicare paid $169,850 for them.

CMS counts 1,993 Medicare patients who saw Dr. Devabhaktuni in 2024. The largest group is 65 to 74, with 796 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Devabhaktuni's median patient age at 74, with 51% women.

In 2024, Dr. Devabhaktuni wrote 3,562 Medicare Part D claims for 611 patients. 83% of them were for generic drugs. CMS names the drug for 3,423 of them, across 38 drugs with 11 or more claims each, at $597,053 in total drug cost. In 2023, CMS named 2,000 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Devabhaktuni for performance year 2024, reported as part of a group. Dr. Devabhaktuni accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 295 general payments to Dr. Devabhaktuni from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novartis Pharmaceuticals Corporation paid the most, $794.